Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing tags : Biotech-beach save search
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $4.9 2.08% 2.04% 36K
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -2.06%
symposium topline medical trial
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
LBPH | $18.01 5.94% 5.61% 500K
|
Manufacturing
|
| O: -0.61%
H: 0.61%
C: -7.83%
pharmaceuticals meeting study
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
conference
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
AADI | $1.81 -0.55% -0.55% 150K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
bioscience update financial results
Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
KPRX | $0.4913 -2.94% -3.03% 160K
|
Manufacturing
|
| O: 2.4%
H: 2.64%
C: -4.18%
kio-101 publication treatment eye study
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
AADI | $1.81 -0.55% -0.55% 150K
|
Manufacturing
|
| O: 0.47%
H: 4.72%
C: 2.83%
report bioscience update results
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
NVNO | $4.9 2.08% 2.04% 36K
|
Manufacturing
|
| O: 2.96%
H: 3.48%
C: -9.7%
enous2024 positive topline meeting trial today
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: 1.51%
H: 11.2%
C: 7.5%
conference growth
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Published: 2024-02-14 (Crawled : 14:00) - biospace.com/
LAB | $2.53 -3.07% -3.16% 2.8M
|
Manufacturing
|
| O: 0.0%
H: 4.29%
C: 1.29%
conference year financial results
PCA 500™-- the world's most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
fda care clearance
Ainos Announces $1.75 Million Follow-On Funding
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
AIMD | $1.04 1.92% 10K
|
Manufacturing
|
| O: -2.59%
H: 5.31%
C: -7.96%
million funding
Ainos, Inc. Announces Stock Consolidation
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
AIMD | $1.04 1.92% 10K
|
Manufacturing
|
| O: -3.28%
H: 3.49%
C: -0.91%
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: -3.39%
H: 4.39%
C: 1.75%
conference growth
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
ELDN | $1.99 26.75% 21.11% 310K
|
Manufacturing
|
| O: -1.67%
H: 0.85%
C: -5.08%
conference pharmaceuticals growth
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
NVNO | $4.9 2.08% 2.04% 36K
|
Manufacturing
|
| O: 0.42%
H: 3.16%
C: -6.32%
device venovalve symposium positive medical trial
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November
Published: 2023-11-01 (Crawled : 15:00) - biospace.com/
LBPH | $18.01 5.94% 5.61% 500K
|
Manufacturing
|
| O: 1.94%
H: 2.72%
C: -2.9%
pharmaceuticals
Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023
Published: 2023-10-30 (Crawled : 17:00) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: -2.78%
H: 0.0%
C: -5.71%
conference program results growth study
ImmunityBio Announces Biological License Application Resubmission for N-803 in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma-In-Situ
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: 7.69%
H: 14.29%
C: 2.14%
resubmission license bladder cancer application
Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly
Published: 2023-10-18 (Crawled : 19:00) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: -2.78%
H: 5.71%
C: 2.86%
study
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.